Currently predicting for Thu, 4 Jun 2026

ESPR Prediction Chart

ESPR Predictions History

Latest community submissions for ESPR.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 30, 2025 $2.82 -1.72% $2.84 V 99.31% 4
Aug 26, 2025 Bullish $2.19 V 1
Aug 4, 2025 $1.45 +3.88% $1.49 V 97.60% 1
Aug 4, 2025 $1.43 +2.42% $1.49 V 96.24% 1
Aug 4, 2025 Bearish $1.49 X 0
gregornimrod gregornimrod Merchant
Dec 24, 2024 Bullish $2.30 V 1
Dec 23, 2024 $2.32 +5.85% $2.24 V 96.52% 1
Dec 23, 2024 $2.27 +3.65% $2.24 V 98.66% 2
Dec 23, 2024 Bullish $2.24 V 1
Dec 16, 2024 $2.40 +6.70% $2.33 V 96.96% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ESPR with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ESPERION THERAPEUTICS
Esperion Therapeutics
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE